Fiocruz

Oswaldo Cruz Foundation an institution in the service of life

Início do conteúdo

Buscar na Fiocruz

Exibindo 825 de 1056 resultados encontrados
Opções avançadas
Data de publicação: 05/02/2021 - 10:19
On the side of Maici river (Aldeia Dudu), an indigenous woman called Potai Pirahã received the first dose of the Covid-19 vaccine. Aftere 28 days, she should get the second dose. Potai Pirahã is part of a group of 713 indigenous people that will be vaccinated in the municipality of Humaitá (in the South of Amazonas). The vaccination in indigenous lands of the area started on January 26th, along with lectures to raise...
Notícias
Data de publicação: 15/01/2021 - 09:21
Nísia Trindade Lima was renominated for the position of President of Fiocruz, for the period of 2021-2024. Lima was elected on the first place of the three-name list unanimously homologated by Fiocruz Advisory Board, which was handed to the Health Minister, Eduardo Pazuello, last November. Fiocruz 2020 elections were the most significant in the institution’s history, with the participation of 4,400 voters - 91.6% of the 4,847...
Notícias
Data de publicação: 15/01/2021 - 09:41
A researcher of the Leônidas & Maria Deane Institute (ILMD/Fiocruz Amazônia) confirms the identification of the origin of the new variant of the Sars-CoV-2 in Amazonas. The new variant was provisionally named B.1.1.28 (K417N / E484K / N501Y). Led by Felipe Naveca, the study suggests that the strains, identified in Japanese travelers that had been in the Amazonian region, evolved from a viral strain in Brazil that is...
Notícias
Data de publicação: 22/01/2021 - 11:55
At the end of the 1st Extraordinary Public Meeting of the Collegiate Board, held on January 17, the Brazilian Health Regulatory Agency (Anvisa) authorized the emergency use of two vaccines against Covid-19: Oxford-AstraZeneca, Fiocruz, and Coronavac, of the Butantan Institute. A historic day for Anvisa and also for Brazil, marking the beginning of vaccination in the country. The emergency request submitted by Fiocruz refers to the 2...
Notícias
Data de publicação: 05/02/2021 - 10:09
On January 29th, Fiocruz officially submited the application to register the Covid-19 vaccine to the Healthy Surveillance Agency (Anvisa), which will allow the Oxford-AstraZeneca immunizer Covid-19 vaccine across the country. “This is another key step in facing the pandemic and it will allow the Brazilian population to have broad access to the vaccine, which will be distributed through the Ministry of Health’s National Immunization...
Notícias
Data de publicação: 12/04/2022 - 17:33
Released this Friday (April 4), the Fiocruz COVID-19 Observatory Report shows maintenance of the falling trend of COVID-19 incidence and mortality indicators. The document highlights that for the first time since May 2020, no Brazilian state has exceeded 0.3 deaths per 100,000 inhabitants. The researchers state that according to these new data it is possible to say that the third epidemic wave in Brazil, with a predominance of Omicron among the...
Notícias
Data de publicação: 15/02/2022 - 10:42
In a geopolitical context marked by disputes and inequalities, there are many economic, social, and environmental challenges in the path of those aiming to reduce these inequalities and achieve better global health outcomes. Based on this point of view, issues such as multilateralism and a possible new world order were discussed last Thursday (February 10) during the first Advanced Seminar in Global Health and Health Diplomacy this year....
Notícias
Data de publicação: 15/02/2022 - 14:38
Looking at the map, the distance between the countries is big. Within the American continent, Mexico is the Spanish-speaking country that is farthest away from Brazil. But the two nations are closer to each other than it may seem. Fiocruz and Mexican institutions have joint projects, a cooperation that can expand even further, judging by the interest demonstrated by consul Héctor Humberto Valezzi Zafra. Together with the deputy consul in...
Notícias
Data de publicação: 25/02/2022 - 15:01
In this role for less than five months, the new Ecuador ambassador in Brazil, Carlos Alberto Velástegui, visited Fiocruz last Friday (February 18) to strengthen the ties between his country and the Foundation. In the company of consul Marco Larrea, he was welcomed by Fiocruz president, Nísia Trindade Lima, and showed interest in defining areas for possible cooperation with Ecuador institutions and in getting to know more about the...
Notícias
Data de publicação: 24/03/2022 - 15:43
At a meeting that took place last Friday (March 19), representatives of Fiocruz and of the Deutsche Forschungsgemeinschaft (DFG), a German non-profit organization that stimulates research, got together to strengthen bilateral cooperation between the institutions and to discuss possible foment partnerships. As a first step in this direction, a workshop was suggested to evaluate the opportunities, identifying possibilities among ongoing projects...
Notícias
Data de publicação: 22/02/2022 - 14:33
This Thursday (17/2) the Fiocruz Genomic Network released new figures on the lineages and variants of the Sars-CoV-2 virus in Brazil. The data are computed every week on the Network’s platform, using data obtained from the EpiCoV platform, from GISAID (Global Initiative on Sharing All Influenza Data), an international platform used to share the genomic data of influenza and Sars-CoV-2 viruses. The Fiocruz Genomic Network site gathers...
Notícias
Data de publicação: 25/02/2022 - 16:17
When he was about to turn 4 years old, Julinho started to attend a day care center near his home. The adaptation was difficult for the adults in the family, who were used to taking care of him all the time. “What if he had a seizure?”, “What if he cried a lot?”, “What if they forgot the medication schedule?”. The questions were frequent. But the boy surprised everyone with his good integration: he didn't...
Notícias
Data de publicação: 22/02/2022 - 16:51
The Oswaldo Cruz Foundation (Fiocruz), through the Immunobiological Technology Institute (Biomanguinhos), provides the first doses of the COVID-19 vaccine (recombinant) produced with the national Active Pharmaceutical Ingredient (API). The first batch of national vaccines was released by the internal quality control of Bio-Manguinhos on 2/14. “The release of the first 100% Brazilian COVID-19 vaccines, now available to the Ministry of...
Notícias
Data de publicação: 04/04/2022 - 12:55
The international partnerships at Fiocruz are governed by various collaborative agreements. The following is a list of the agreements currently in force.  North-South In France, FIOCRUZ is the only Brazilian institution that belongs to the Pasteur World Network, which maintains projects with the Alliance Nationale pour les Sciences de la Vie et la Santé (Aviesan), a French national institution that includes the Institut...
Páginas Institucionais (antigas)
Data de publicação: 04/04/2022 - 12:54
The operational activities pertaining to international exchange feature drafting agreements, contracts, and/or memoranda of understanding with institutions from partner countries, procedures for time spent abroad, orientation on applications for special passports and requests for third party notes, and receiving foreign colleagues at the Foundation. International Agreements These are formal instruments for establishing and strengthening...
Páginas Institucionais (antigas)
Data de publicação: 08/02/2022 - 16:00
The Fiocruz Genomic Network has released new data on the status of lineages and variants of the Sars-CoV-2 in Brazil, based on the genomic surveillance produced by the Network and by other initiatives. According to the publication, while in December 39.4% of sequenced genomes belonged to the Omicron variant, in January 2022 this rate rose to 95.9%. The variant has now been found in all of the country’s regions. The Network Report shows...
Notícias
Data de publicação: 08/03/2022 - 15:43
Vaccination can protect the population against contamination, hospitalization, and death by COVID-19, even in socially vulnerable communities with high transmission rates. This is one of the main conclusions of a new paper of the "Vacina Maré" (vaccinate Maré, in english) research, which evaluates the effectiveness of the Fiocruz/AstraZeneca vaccine against getting sick with COVID-19, in Complexo da Maré, a complex...
Notícias
Data de publicação: 16/02/2022 - 16:01
A technological innovation may contribute to the quest for the leprosy elimination, one of the humanity oldest diseases. An international team of scientists, led by the Oswaldo Cruz Institute (IOC/Fiocruz), in partnership with Microsoft AI for Health and the Novartis Foundation, has developed a diagnostic assistant, based on artificial intelligence, which can help identify suspected leprosy lesions. The technology has been called AI4Leprosy...
Notícias
Data de publicação: 23/03/2022 - 16:44
Unitaid, the global health agency connected to the WHO, will be financing the implementation of the project for Injectable Pre-Exposure Prophylaxy in Brazil, using long-acting Cabotegravir. With only six injections per year, the method has proven to be more effective than daily oral PrEP in terms of reducing the risk of infection by the virus. The project will be coordinated by the Evandro Chagas National Infectiology Institute (INI/Fiocruz) in...
Notícias
Data de publicação: 31/03/2022 - 18:30
The implementation of a World Health Organization (WHO) hub for Pandemic and Epidemic Intelligence led the WHO to organize the visit of a top-level delegation, together with the Pan-American Health Organization (PAHO), to Fiocruz last Thursday (March 24). Led by the assistant director-general of the Division of Intelligence and Surveillance Systems for Emergencies in Health, Chikwe Ihekweazu, who is also the director of the hub, and Socorro...
Notícias
Data de publicação: 21/03/2022 - 17:54
The war in Ukraine has been thoroughly divulged, discussed, and explained on all social media platforms, in Brazil and abroad. Its geopolitical, economic, and social consequences have also been explored by specialists of all fields of knowledge and geographical position. However, there is one dimension that has been left out by this widely encompassing debate: the matter of health. On the other hand, more attentive readers will certainly not...
Notícias
Data de publicação: 16/03/2022 - 14:24
The Global Network of Human Milk Banks (rBLH) has already started organizing the celebrations of World Human Milk Donation Day - 19 May. The first step consists in choosing the slogan for social mobilization for the donation of human milk in 2022. Applications must be submitted between the 14th and the 25th of March. “Human Milk Donation: Solidarity and Peace in a Globalized World” is the theme of social mobilization chosen for...
Notícias
Data de publicação: 23/03/2022 - 16:42
A study by researchers of Fiocruz and of the University of Columbia has identified promising results in a combination of antiviral drugs for the treatment of COVID-19. Scientists showed that there is a synergy between the substances, inhibiting the enzymes that allow Sars-CoV-2 to multiply more effectively. Together, the drugs may reduce viral replication about ten times more than if taken separately. The drugs studied are already...
Notícias
Data de publicação: 08/04/2022 - 15:33
Last Tuesday (March 29), Fiocruz and Drugs for Neglected Diseases initiative (DNDi) signed a Memorandum of Understanding for dengue fever research and treatment. The occasion also sealed a Strategic Research Alliance between the two institutions and the joint submission of a project to the Finep Public Call for Neglected Diseases. In addition to signing the Memorandum of Understanding for dengue fever, the occasion sealed a Strategic...
Notícias

Pages

Back to the topBack